Evidence map›Paper›PMID 29924910›Full record

ArticleChemMedChem2018

Differentiating Antiproliferative and Chemopreventive Modes of Activity for Electron-Deficient Aryl Isothiocyanates against Human MCF-7 Cells.

Ruthellen H Anderson, Cody J Lensing, Benjamin J Forred, Michael W Amolins, Cassandra L Aegerter, Peter F Vitiello, Jared R Mays

Abstract read
In one paragraph

Article in ChemMedChem, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Ruthellen H AndersonDepartment of Chemistry, Augustana University, 2001 South Summit Avenue, Sioux Falls, SD, 57197, USA.
Cody J LensingDepartment of Chemistry, Augustana University, 2001 South Summit Avenue, Sioux Falls, SD, 57197, USA.
Benjamin J ForredEnvironmental Influences on Health and Disease Group, Sanford Research, 2301 East 60th Street North, Sioux Falls, SD, 57104, USA.
Michael W AmolinsDepartment of Chemistry, Augustana University, 2001 South Summit Avenue, Sioux Falls, SD, 57197, USA.
Cassandra L AegerterEnvironmental Influences on Health and Disease Group, Sanford Research, 2301 East 60th Street North, Sioux Falls, SD, 57104, USA.
Peter F VitielloEnvironmental Influences on Health and Disease Group, Sanford Research, 2301 East 60th Street North, Sioux Falls, SD, 57104, USA.
Jared R MaysDepartment of Chemistry, Augustana University, 2001 South Summit Avenue, Sioux Falls, SD, 57197, USA.ORCID 0000-0002-6867-3581
Sanford Health · USAugustana University · US

Funding

Wichozani-A Healthy Lifestyle for Rural American Indian Youth through Cultural and Physical Activities: A Community-Based Participatory Research StudyP20GM103443 · NIGMS · UNIVERSITY OF SOUTH DAKOTA · PI Victor Chester Huber · 2012 to 2026
$58.1M
WESTCORE DNA SEQUENCING AND GENOTYPING CORE FACILITYP20RR016479 · NCRR · UNIVERSITY OF SOUTH DAKOTA · PI GOODMAN, BARBARA EASON · 2001 to 2011
$32.2M
Yeast 2 HybridP20GM103620 · NIGMS · SANFORD RESEARCH/USD · PI ROUX, KYLE J · 2013 to 2023
$24.2M
The Impact of PD-1 Inhibition on Immune-Response to ChemoradiotherapyP20GM103548 · NIGMS · SANFORD RESEARCH/USD · PI MISKIMINS, W KEITH · 2012 to 2020
$20.8M
Hyperoxic Modulation of Thioredoxin SignalingR01HL135112 · NHLBI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI VITIELLO, PETER · 2017 to 2021
$2.0M
Sanford Research/USD Science Educator Pediatric Health and Research FellowshipR25HD072596 · NICHD · SANFORD RESEARCH/USD · PI ELLIOTT, AMY J, PEARCE, DAVID A. · 2012 to 2016
$474k
NCRR NIH HHS P20 RR016479NHLBI NIH HHS R01 HL135112NICHD NIH HHS R25 HD072596NIGMS NIH HHS P20 GM103443NIGMS NIH HHS P20 GM103548NIGMS NIH HHS P20 GM103620
6 · The paper itself

Abstract

The consumption of Brassica vegetables provides beneficial effects through organic isothiocyanates (ITCs), products of the enzymatic hydrolysis of glucosinolate secondary metabolites. The ITC l-sulforaphane (l-SFN) is the principle agent in broccoli that demonstrates several modes of anticancer action. While the anticancer properties of ITCs like l-SFN have been extensively studied and l-SFN has been the subject of multiple human clinical trials, the scope of this work has largely been limited to those derivatives found in nature. Previous studies have demonstrated that structural changes in an ITC can lead to marked differences in a compound's potency to 1) inhibit the growth of cancer cells, and 2) alter cellular transcriptional profiles. This study describes the preparation of a library of non-natural aryl ITCs and the development of a bifurcated screening approach to evaluate the dose- and time-dependence on antiproliferative and chemopreventive properties against human MCF-7 breast cancer cells. Antiproliferative effects were evaluated using a commercial MTS cell viability assay. Chemopreventive properties were evaluated using an antioxidant response element (ARE)-promoted luciferase reporter assay. The results of this study have led to the identification of 1) several key structure-activity relationships and 2) lead ITCs for continued development.

Indexed as

Antineoplastic AgentsAntioxidant Response ElementsAntioxidantsBenzene DerivativesCell ProliferationCell SurvivalDose-Response Relationship, DrugDrug Screening Assays, AntitumorGene ExpressionHumansIsothiocyanatesMCF-7 CellsMolecular StructureSmall Molecule LibrariesStructure-Activity RelationshipAntineoplastic AgentsAntioxidantsBenzene DerivativesIsothiocyanatesSmall Molecule Librariesantioxidantsantiproliferationisothiocyanatesstructure-activity relationshipssulforaphane

Identifiers

PMID29924910
PMCPMC6105534
OpenAlexW2809881614

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.